Medtronic Cardiac Surgery PMCF Registry
Medtronic Cardiac Surgery Post Market Clinical Follow-up Registry
1 other identifier
observational
2,700
10 countries
26
Brief Summary
This registry is being conducted to support ongoing post-market surveillance activities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2019
Longer than P75 for all trials
26 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2019
CompletedFirst Posted
Study publicly available on registry
August 29, 2019
CompletedStudy Start
First participant enrolled
December 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2039
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2039
April 13, 2026
April 1, 2026
20.1 years
August 19, 2019
April 8, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Identify unique failure modes
10 years
Identify trends in adverse device effects
10 years
Study Arms (1)
Surgical Valve Replacement and/or Repair Patients
Interventions
Surgical heart valve repair products.
Surgical heart valve replacement products.
Eligibility Criteria
Subjects requiring heart valve therapy replacement and/or repair.
You may qualify if:
- Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
- Patient has or is intended to receive or be treated with an eligible product
- Patient is within enrollment window of treatment/therapy received at the time of their initial Registry enrollment, or meets criteria for retrospective enrollment
You may not qualify if:
- Patient who is, or is expected to be, inaccessible for follow-up
- Patient prohibited from participation by local law
- Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or device study that may confound results
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (26)
WellStar Kennestone Hospital
Marietta, Georgia, 30060, United States
University of Michigan
Ann Arbor, Michigan, 48109, United States
Mount Sinai Medical Center
New York, New York, 10029, United States
Saint Francis Hospital
Roslyn, New York, 11576, United States
Saint Josephs Hospital Health Center
Syracuse, New York, 13203, United States
Duke University Medical Center
Durham, North Carolina, 27710, United States
University Hospitals Cleveland
Cleveland, Ohio, 44106, United States
University of Pittsburgh Medical Center UPMC Presbyterian
Pittsburgh, Pennsylvania, 15213, United States
Baylor St. Luke's Medical Center
Houston, Texas, 77030, United States
The Heart Hospital Plano
Plano, Texas, 75093, United States
Inova
Falls Church, Virginia, 22042, United States
Allgemeines Krankenhaus - Universitätskliniken Wien
Vienna, 1090, Austria
UZ Leuven
Leuven, 3000, Belgium
Hôpital Haut-Lévêque - CHU de Bordeaux
Pessac, 33604, France
Schüchtermann-Klinik
Bad Rothenfelde, 49214, Germany
Herzzentrum Dresden GmbH Universitätsklinik
Dresden, 01307, Germany
Universitätsklinikum Düsseldorf
Düsseldorf, 40225, Germany
Albertinen-Herz- und Gefäßzentrum
Hamburg, 22457, Germany
Herzzentrum Leipzig
Leipzig, Germany
Deutsches Herzzentrum München Klinik an der TU München
München, 80636, Germany
Onassis Cardiac Surgery Center
Athens, 17674, Greece
Ospedale Pasquinucci Massa
Massa, 54100, Italy
IRCCS Policlinico
San Donato, Italy
Leids Universitair Medisch Centrum
Leiden, Netherlands
Hospital Regional Universitario Carlos Haya Málaga - Hospital General
Málaga, 29010, Spain
Inselspital - Universitätsspital Bern
Bern, 3010, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 10 Years
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2019
First Posted
August 29, 2019
Study Start
December 2, 2019
Primary Completion (Estimated)
December 31, 2039
Study Completion (Estimated)
December 31, 2039
Last Updated
April 13, 2026
Record last verified: 2026-04